CURRENT ISSUE
Watch Online the Live Sessions of ISWWTA 2015 Rishikesh on Youtube.Visit:https://www.youtube.com/user/ayushdarpan/
Previous issues of AYUSH DARPAN in Hindi is now available online visit:http://ayushdarpan.org

Search Engine

Sunday, 16 October 2016

Bioengineers' sweat sensor monitors glucose

IMAGEResearchers at The University of Texas at Dallas are sweating the small stuff in their efforts to develop a wearable device that can monitor an individual's glucose level via perspiration on the skin.
In a study recently published online in the journal Sensors and Actuators B: Chemical, Dr. Shalini Prasad, professor of bioengineering in the Erik Jonsson School of Engineering and Computer Science, and her co-authors demonstrated the capabilities of a biosensor they designed to reliably detect and quantify glucose in human sweat.
The team has previously demonstrated that their technology can detect cortisol in perspiration.
But for diabetics and those at risk for diabetes, self-monitoring of blood glucose, or blood sugar, is an important part of managing their conditions.
"Fitness trackers that monitor heart rate and step count are very popular, but wearable, non-invasive biosensors would be extremely beneficial for managing diseases," said Prasad, the Cecil H. and Ida Green Professor in Systems Biology Science.
Typical home-use blood glucose monitors require a user to obtain a small blood sample, usually through the prick of a finger and often several times a day. However, the UT Dallas textile-based sensor detects glucose in the small amount of ambient sweat on a person's skin.
"In our sensor mechanism, we use the same chemistry and enzymatic reaction that are incorporated into blood glucose testing strips," Prasad said. "But in our design, we had to account for the low volume of ambient sweat that would be present in areas such as under a watch or wrist device, or under a patch that lies next to the skin."
Prasad said that researchers who work with sweat often use a process called iontophoresis, which sends an electric current through the skin to generate enough perspiration for sensing experiments. However, because this method can lead to rashes and burns on the skin, the team sought an alternative that would work with small amounts of sweat.
Their design works with volumes of sweat less than a microliter, which is the approximate amount of liquid that would fit in a cube the size of a salt crystal.
The technology also provides a real-time response in the form of a digital readout.
Prasad and bioengineering doctoral student Rujuta Munje, lead author of the journal article, incorporated an off-the-shelf polymer-based textile material in their glucose sensor and used UT Dallas clean-room facilities to construct the electronic elements. The prototype is a small, flexible, rod-shaped device about an inch long.
"We used known properties of textiles and weaves in our design," Prasad said. "What was innovative was the way we incorporated and positioned the electrodes onto this textile in such a way that allows a very small volume of sweat to spread effectively through the surface."
Typical blood glucose testing strips also contain a molecule that ultimately amplifies the signal from the chemical reactions on the strip enough to register electronically on a monitoring device. But if used in a device that is worn next to the skin, those molecules can be irritating, Prasad said, which presented another challenge.
To ensure that such a tiny amount of sweat would generate a strong enough signal, Prasad and Munje modified the surface topography of the textile material.
"Our modifications allow this material to entrap glucose oxidase molecules, which effectively amplifies the signal," Prasad said. "We did it this way because we are thinking about possible commercialization -- to make these, we need a fabrication process that is not complex."
Prasad and Munje also were able to account for the fact that the chemistry of a person's sweat changes throughout the day.
"Glucose is a tricky molecule to monitor because other factors can confound a signal," Prasad said. "For example, the pH, or acidity, of your sweat can vary greatly depending on the circumstances."
She noted that when individuals exercise or are under stress, the level of other compounds in their sweat, such as cortisol and lactic acid, change as well, and these can interfere with glucose detection.
"We have shown that with our technology, we address three critical issues: low volume of ambient sweat, interference from other compounds and pH swings," Prasad said
Prasad and Munje tested their prototype using samples of human sweat from donors.
While a consumer product based on the technology is still a few years away, the concept was developed with commercialization and scaled-up production in mind.
"At this point, we are thinking of this sensor as something you use for a day and toss out, and we believe it could easily be incorporated into existing consumer electronics platforms," Prasad said. "We're very excited about the potential for licensing this technology."
The research was supported by the Cecil H. and Ida Green endowed fellowship at UT Dallas.
Researchers at UT Dallas and elsewhere have investigated whether glucose found in other bodily fluids -- such as urine and tears -- might be used to track glucose levels, further eliminating the need for invasive blood draws. Google, for example, is investigating a smart contact lens designed to measure glucose levels in tears.
The Centers for Disease Control and Prevention estimate that 29 million people in the United States have diabetes and 86 million have prediabetes.
Source:UNIVERSITY OF TEXAS AT DALLAS

Want to optimize those 10,000 (or fewer) steps? Walk faster, sit less

That popular daily target of 10,000 steps is a worthwhile goal, but a new study at Oregon State University suggests that if you find that unattainable, don't despair - a smaller number, especially at moderate or greater intensity, can lead to health benefits too.
It's especially helpful if 3,000 of the steps come at a brisk pace, and limiting sedentary time also plays a role in healthy readings for cholesterol and other risk factors.
The average American takes between 5,000 and 7,000 steps per day, researchers say.
"Some physical activity is better than none, and typically more is better than less," said John Schuna Jr., assistant professor of kinesiology in OSU's College of Public Health and Human Sciences.
"When it comes to steps, more is better than fewer, and steps at higher cadences for a significant amount of time are beneficial. A good target for healthy adults is 150 minutes per week spent at 100 or more steps per minute. And in terms of time spent sedentary, less is better - you want to spend as little time not moving as possible within reason."
Schuna, lead author Catrine Tudor-Locke of the University of Massachusetts and six other researchers analyzed data from 3,388 participants age 20 and older in a National Health and Nutrition Examination Survey.
Their findings were recently published in the journal Medicine & Science in Sports & Exercise.
The research builds on earlier studies, many of which relied on self-reported estimates of activity levels, which tend to run high, or accelerometer data using proprietary output measures (e.g., activity counts/minute), and also failed to take cadence - steps per minute - into account. A cadence of 100 steps per minute or greater is widely accepted as the threshold for moderate-intensity activity in adults.
In addition to minute-by-minute step data, the researchers looked at relationships between step-defined physical activity and various cardiometabolic risk factors for the survey participants - such as waist circumference, blood pressure, fasting glucose, insulin, and cholesterol levels, as well as body mass index.
Among male participants, only the highest quintile - the top one-fifth - had a median of more than 10,000 steps per day, checking in at 12,334. Among women, the top quintile's median was 9,824.
Beyond just total step counts, the research looked at daily "peak 30-minute cadence" - the average number of steps in a participant's most vigorous 30 minutes, which weren't necessarily consecutive minutes. To measure sedentary time, researchers used the percentage of accelerometer time per day that showed no step-based movement.
Among all survey participants, only the top quintile had a median peak cadence - 96 steps per minute - that was in line with accepted physical activity guidelines of 30 minutes a day at 100 steps per minute.
Nevertheless, analysis across all quintiles showed a strong relationship between higher cadences - walking more briskly as opposed to less briskly - and favorable numbers in the cardiometabolic risk categories.
The same held true for number of steps, whether above or below the 10,000-step threshold. And higher percentages of sedentary time were linked to less-favorable values in several risk factors.
While FitBit, Garmin and other fitness trackers might be responsible for the current 10,000-step fixation, Schuna notes that the magic number's roots trace to 1960s Japan. From a fitness craze inspired by the 1964 Tokyo Olympics sprang the first commercial pedometer, the manpo-kei. In Japanese, manpo-kei literally means "10,000 steps meter."
"One of the questions has always been, what if one person with 10,000 steps per day accumulates nearly all of them in a two-hour time block, and another stretches them over 15 hours - does it matter in terms of health effects?" Schuna said.
"This is a big debate in the field, with a couple of intertwined questions. Current evidence does suggest that moderate to vigorous activity and sedentary time have a certain amount of independence from each other in terms of health effects. But if you're getting two or three hours of moderate to vigorous activity every day, even if you're relatively sedentary the rest of the time, it's hard to imagine the sedentary time would completely ameliorate or wipe out the health benefits associated with that level of activity."
IMAGEA person who averages 10,000 or more steps/day typically accumulates at least 150 minutes a week of moderate to vigorous activity, Schuna said.
"Now there is an additional caveat regarding the manner in which physical activity is accumulated to meet current physical activity guidelines, which states that aerobic activity should be accumulated in bouts of at least 10 minutes in duration.," he said. "If we take this into consideration, it becomes more difficult to determine whether or not someone is meeting the physical activity guidelines using step counts alone. That aside, averaging 10,000 or more steps/day puts you in the top 15 percent of adults in terms of step-defined physical activity."
Schuna envisions a future in which wearable fitness trackers will feature apps that make minute-by-minute data available to the user, as research-grade accelerometers now do to scientists.
"That's along this paradigm of personalized medicine," he said. "In the future, everyone will have his or her genome sequenced, and from that we'll be looking for specific markers that predispose people to higher risks for certain conditions. The physical activity and sleep data we collect from wearable devices will be used to track compliance to individualized behavior prescriptions while attempting to optimize each individual's health."
Source:OREGON STATE UNIVERSITY

Friday, 14 October 2016

Aerobic Exercise Beneficial to People With Type 1 Diabetes on Insulin Pump



Type 1 diabetes (T1D) is a chronic condition in which the pancreas produces little or no insulin. T1D patients on insulin pumps stand to benefit by engaging in aerobic exercise, revealed a team researchers who conducted a three-month observational study on two groups of diabetes patients.When compared to patients in the study who did not exercise, patients in the study group who engaged in aerobic exercise benefited by improving their metabolic control, reducing their insulin requirement, and a saw a reduction in the number of hyperglycemic events they experienced. The study, carried out by a team of researchers in Milan, Italy, and Miami, Florida, will be published in a future issue of Cell Transplantation.
The clinical study focused on middle-aged T1D patients on insulin pump therapy and aimed at gathering data on metabolic activity, and inflammatory and autoimmune parameters. Having conducted similar studies previously with animals modeled with T1D, the researchers hypothesized that aerobic, physical activity might also positively regulate autoimmunity and help prevent diabetes-related complications in humans.

"We found that being physically active can improve glycemic control for patients with type 1 diabetes," said study co-author Dr. Livio Luzi of the Diabetes Research Institute at the University of Miami Miller School of Medicine in Miami, Florida and the Metabolism Research Center at IRCCS Policlinico San Donato in San Donato Milanese, Italy, who worked with colleagues based in Milan, Italy. "Our results suggest that an educational program addressed to T1D patients, and focused on insulin injecting monitoring, diet, and exercise, is highly advantageous for management of T1D. "

According to the researchers, the six patients in the exercise arm of the study (ACT) when compared to the seven study patients that did not exercise and were sedentary (SED), seemed to have more responsible behavior in monitoring their glucose levels. 

They concluded that further studies with larger groups of participants should be carried out, but that their results on a small number of patients should be considered "primary predictors of exercise-induced metabolic improvements in T1D patients."

"The current study provides physiological data that demonstrate exercise is an important factor in improving and managing type 1 diabetes," said Rodolfo Alejandro of the University of Miami School of Medicine in Miami, Florida and section editor for Cell Transplantation. "With the increasing rate of diabetes, including an exercise program as part of treatment is highly recommended and, when coupled with insulin therapy, may yield better results for patients. Future studies should explore mechanisms of action related to exercise-mediated immunomodulation with a larger sample of the population." 

Source: Eurekalert

Practice Meditation and Improve Your Emotional Health



Mindfulness, a moment-by-moment awareness of one's thoughts, feelings and sensations, has gained worldwide popularity as a way to promote health and well-being.Mindfulness, a moment-by-moment awareness of one's thoughts, feelings and sensations, has gained worldwide popularity as a way to promote health and well-being.
Meditation can help tame your emotions even if you're not a mindful person, suggests a new study from Michigan State University. Reporting in the journal Frontiers in Human Neuroscience, psychology researchers recorded the brain activity of people looking at disturbing pictures immediately after meditating for the first time. These participants were able to tame their negative emotions just as well as participants who were naturally mindful. 

"Our findings not only demonstrate that meditation improves emotional health, but that people can acquire these benefits regardless of their 'natural' ability to be mindful," said Yanli Lin, an MSU graduate student and lead investigator of the study. "It just takes some practice."

The study, conducted in Jason Moser's Clinical Psychophysiology Lab, attempted to find out. 

Researchers assessed 68 participants for mindfulness using a scientifically validated survey. The participants were then randomly assigned to engage in an 18-minute audio guided meditation or listen to a control presentation of how to learn a new language, before viewing negative pictures (such as a bloody corpse) while their brain activity was recorded. 

The participants who meditated - they had varying levels of natural mindfulness - showed similar levels of "emotion regulatory" brain activity as people with high levels of natural mindfulness. In other words their emotional brains recovered quickly after viewing the troubling photos, essentially keeping their negative emotions in check.

In addition, some of the participants were instructed to look at the gruesome photos "mindfully" (be in a mindful state of mind) while others received no such instruction. Interestingly, the people who viewed the photos "mindfully" showed no better ability to keep their negative emotions in check.

This suggests that for non-meditators, the emotional benefits of mindfulness might be better achieved through meditation, rather than "forcing it" as a state of mind, said Moser, MSU associate professor of clinical psychology and co-author of the study.

"If you're a naturally mindful person, and you're walking around very aware of things, you're good to go. You shed your emotions quickly," Moser said. "If you're not naturally mindful, then meditating can make you look like a person who walks around with a lot of mindfulness. 

But for people who are not naturally mindful and have never meditated, forcing oneself to be mindful 'in the moment' doesn't work. You'd be better off meditating for 20 minutes."

Source: Newswise

How the gut microbiome may help us prevent IBD

Breakthroughs in basic and translational research have the potential to change the lives of patients suffering from disease. In this Cellular and Molecular Gastroenterology and Hepatology (CMGH) research update, we highlight the most noteworthy research recently published in the journal, including a study offering the first example of a preventative approach to inflammatory bowel disease (IBD) therapy. We also look at how high altitude levels impact progression of IBD. And finally we take a look inside the pig and its role in GI research.
Please find summaries below. To learn more about any of the studies summarized here, or to speak with the study authors, please email media@gastro.org.
First Look at a Preventive Approach to IBD Therapy
A Disease-Associated Microbial and Metabolomics State in Relatives of Pediatric Inflammatory Bowel Disease Patients
http://www.cmghjournal.org/article/S2352-345X(16)30074-1/fulltext
By Jonathan P. Jacobs, et al.
While previous studies have speculated that changes to the gut microbiome cause disease, these have only assessed healthy or diseased subjects and not proved cause and effect. However, this study by Jonathan P. Jacobs and colleagues directly links a disease-associated microbiome to disease risk in genetically- and environmentally-susceptible individuals. The authors report that the microbiome is altered in a disease-associated pattern, also known as dysbiosis, in some healthy relatives of pediatric IBD patients. The subset of relatives with dysbiosis had biochemical evidence signaling they were in a pre-disease state, i.e. increased fecal calprotectin despite no clinical symptoms. If future studies show that the healthy relatives with dysbiosis have a clinically significant increased risk of developing IBD, it may be possible to intervene before disease onset. Such an intervention could be aimed at restoring a normal microbiome or at other aspects of intestinal health, and would be the first example of a preventative approach to IBD therapy.
How High Altitude Levels Impact Progression of IBD
Hypoxia Positively Regulates the Expression of pH-Sensing G-Protein-Coupled Receptor OGR1 (GPR68)
http://www.cmghjournal.org/article/S2352-345X(16)30073-X/fulltext
By Cheryl de Vallière, et al.
Inflammation is accompanied by reduced oxygen delivery, or hypoxia, within the intestinal lining. Hypoxia has been shown to modify protein expression patterns that may, in turn, modify colitis progression. For example, high altitude exposure, which reduces oxygen delivery, can elicit IBD relapses. Cheryl de Vallière and colleagues report that, in IBD patients, but not healthy volunteers, exposure to simulated high altitude conditions increased expression of cell surface proteins that can sense local environmental acidification. These may be activated by local inflammation-associated acidification to trigger intracellular signaling pathways that lead to disease progression in IBD. Direct targeting of pathways that allow local acid sensing may have therapeutic benefit in both IBD and ischemic enterocolitis, a condition that occurs when blood flow to part of the large intestine is reduced.
IBreakthroughs in basic and translational research have the potential to change the lives of patients suffering from disease. In this Cellular and Molecular Gastroenterology and Hepatology (CMGH) research update, we highlight the most noteworthy research recently published in the journal, including a study offering the first example of a preventative approach to inflammatory bowel disease (IBD) therapy. We also look at how high altitude levels impact progression of IBD. And finally we take a look inside the pig and its role in GI research.
Please find summaries below. To learn more about any of the studies summarized here, or to speak with the study authors, please email media@gastro.org.
First Look at a Preventive Approach to IBD Therapy
A Disease-Associated Microbial and Metabolomics State in Relatives of Pediatric Inflammatory Bowel Disease Patients
http://www.cmghjournal.org/article/S2352-345X(16)30074-1/fulltext
By Jonathan P. Jacobs, et al.
While previous studies have speculated that changes to the gut microbiome cause disease, these have only assessed healthy or diseased subjects and not proved cause and effect. However, this study by Jonathan P. Jacobs and colleagues directly links a disease-associated microbiome to disease risk in genetically- and environmentally-susceptible individuals. The authors report that the microbiome is altered in a disease-associated pattern, also known as dysbiosis, in some healthy relatives of pediatric IBD patients. The subset of relatives with dysbiosis had biochemical evidence signaling they were in a pre-disease state, i.e. increased fecal calprotectin despite no clinical symptoms. If future studies show that the healthy relatives with dysbiosis have a clinically significant increased risk of developing IBD, it may be possible to intervene before disease onset. Such an intervention could be aimed at restoring a normal microbiome or at other aspects of intestinal health, and would be the first example of a preventative approach to IBD therapy.
How High Altitude Levels Impact Progression of IBD
Hypoxia Positively Regulates the Expression of pH-Sensing G-Protein-Coupled Receptor OGR1 (GPR68)
http://www.cmghjournal.org/article/S2352-345X(16)30073-X/fulltext
By Cheryl de Vallière, et al.
Inflammation is accompanied by reduced oxygen delivery, or hypoxia, within the intestinal lining. Hypoxia has been shown to modify protein expression patterns that may, in turn, modify colitis progression. For example, high altitude exposure, which reduces oxygen delivery, can elicit IBD relapses. Cheryl de Vallière and colleagues report that, in IBD patients, but not healthy volunteers, exposure to simulated high altitude conditions increased expression of cell surface proteins that can sense local environmental acidification. These may be activated by local inflammation-associated acidification to trigger intracellular signaling pathways that lead to disease progression in IBD. Direct targeting of pathways that allow local acid sensing may have therapeutic benefit in both IBD and ischemic enterocolitis, a condition that occurs when blood flow to part of the large intestine is reduced.
Insights from Inside the Pig
Large Animal Models: The Key to Translational Discovery in Digestive Disease Research
http://www.cmghjournal.org/article/S2352-345X(16)30104-7/fulltext
By Amanda Ziegler, et al.
The use of animal models has been instrumental in studying mechanisms of digestive pathophysiology, but there may be no better model than the pig, according to Ziegler and colleagues' review. The pig GI tract shares a number of similarities with the human GI tract that rodents do not, and in certain settings offers distinct advantages for studying GI physiology and pathophysiology. The pig has provided important tools and insight in intestinal ischemia/reperfusion injury, intestinal mucosal repair, as well as new insights into esophageal injury and repair. Porcine model development has taken advantage of the size of the animal, allowing increased surgical and endoscopic access. In addition, cellular tools such as the porcine IPEC-J2 intestinal cell line and porcine enteroids are providing the methodology to translate basic science findings using in depth mechanistic analyses. The authors believe that porcine models hold great promise for the future of clinically relevant digestive disease research.
Want more basic and translational research? Review other CMGH articles in press by visitinghttp://cmghjournal.org/inpress.
Source:AMERICAN GASTROENTEROLOGICAL ASSOCIATION

DOCTOR EXPLAINS HOW REVERSING TYPE 2 DIABETES STARTS WITH IGNORING THE GUIDELINES ON CARBOHYDRATES

Obesity is a life-threatening disease not taken on by choice. Yet, thanks at least in part to our society’s glorification of thinness, many have preconceived notions about those who are obese, believing they are to blame for their situation — that they are simply lazy, gluttonous, and lack the willpower to change.But as Sarah Hallberg, the Medical Director of the Medically Supervised Weight Loss Program at IU Health Arnett, United States, notes, obesity is a hormonal disease, not a lifestyle choice. And one of those hormones is insulin.
The body processes insulin when glucose is released into the bloodstream following carbohydrate consumption. Usually, this insulin responsF
As for the general recommendations put forth by the American Diabetes Association (ADA), she explains that, “The general recommendations are to tell patients with type 2 to consume 40-65g of carbohydrate per meal, plus more at snacks. We are essentially recommending that they eat exactly what’s causing their problem.”
Hallberg notes that, when treating type 2 patients with insulin, glucose levels rise after eating carbs, as does the need for insulin. But because insulin is the body’s fat storage hormone, this causes hunger fat to be stored, making it difficult for patients to lose weight.
“The ADA guidelines specifically state that there is inconclusive evidence to recommend a specific carbohydrate limit. Nowhere in the ADA guidelines is the aim of reversing type 2 diabetes. This needs to be changed because type 2 can be reversed, in many if not most situations, especially if we start early,” she says.As for Hallberg’s diet recommendation, she points out that, though the body needs proteins and essential fatty acids, it doesn’t have a certain amount of daily carbohydrates it must adhere to for health purposes.
“When our patients decrease their carbs, their glucose goes down and they don’t need as much insulin. Their insulin levels drop fast. Low-carb intervention works so fast that we can literally pull people off hundreds of units of insulin in days to weeks,” Hallberg explains.
But she is also sure to explain that low-carb does not refer to no carbs, nor is it necessarily high in protein. “My patients eat fat, and a lot of it. Fat is the only macronutrient that is going to keep our blood glucose and insulin levels low,” she says.
Her evidence comes in the form a study her clinic performed, where 50 people with type 2 diabetes were treated with her recommended low-carb high-fat diet. She treated another 50 patients with ADA guidelines. After six months, the study concluded that the patients treated with Hallberg’s recommended diet were able to decrease their insulin by nearly 500 units a day, on average. Those in the ADA group, however, had to boost their insulin by an average of 350 units a day.
So can type 2 diabetes be reversed? “Cured would imply that it can’t come back, and if they start eating excessive carbs again it will, but they don’t have diabetes any longer,” Hallberg urges.
Watch her full presentation below:

More Interesting Information On How 6 Test Subjects Reverse Diabetes In 30 Days

In the film, Simply Raw: Reversing Diabetes in 30 Days, six test subjects were used, all of whom had varying lifestyles and conditions but were all diabetic – five were type 2 and one was type 1. Each subject was taking insulin.
Before we get into the results of this film, let’s take note of what is established about type 1 and type 2 diabetes. This information is from The National Diabetes Education Program:
Type 1 diabetes – The body does not make insulin. Insulin helps the body use glucose from food for energy. People with type 1 need to take insulin every day.
Type 2 diabetes – The body does not make or use insulin well. People with type 2 often need to take pills or insulin. Type 2 is the most common form of diabetes.
The participants of the program were as follows:
  • Austin (age 25) was not only a type 1 diabetic, but he also had a drinking problem.
  • Kirt (age 25) had a blood sugar reading of 1200. Normal is below 100. His doctor told him, “You should be dead.”
  • Bill (age 58) was seeing a cardiologist and had neuropathy. He could not feel his feet.
  • Michelle (age 36) was quite obese.
  • Henry (age 58) took insulin plus 9 pills daily. Blood sugar was at 464.
  • Pam (62) was quite obese. Her father, brother, and sister are also diabetic.
  • The Method

    The approach Gabriel Cousens takes to cure people of diabetes is all about changing their diet. According to him, research shows that in terms of health, meat eaters have 4 times more breast cancer, 3.6 times more prostate cancer, 4 times more diabetes, and much higher rates of chronic disease in general, than their vegan counterparts. If you’re just having milk, that’s 3 times more leukemia. 
    Given his position on diet, he believes in taking a mainly raw approach to eating and consuming a plant based diet. His team prepares raw, well-balanced and whole meals for the test subjects throughout the 30 day period. The food becomes their medicine.
    With medical supervision, all of the subjects took their medication as needed and ate the food that is provided to them by Gabriel and his team at the Tree Of Life Rejuvenation Center.

    Results

    By Day 3 of the program Kirt, Bill and Henry were able to stop taking insulin and medication. Their blood sugar levels had already dropped to the normal range after just 3 days of changing their diet. Pam was able to cut her insulin intake by 1/3. Austin, the type 1 diabetic, was able to cut his insulin intake down to half. And Michelle saw her blood sugar at around 362. This discouraged her to the point where she didn’t want to stay in the program any longer, although she did.
    By day 12 of the program, Henry’s blood sugar had dropped 256 points compared to day 1. He was not using medication to lower his blood sugar levels. Although he was seeing great results, Henry felt he was too old for the program and requested to go home. His family arrived on day 17 and he went home. By that time, he was no longer taking 17 medications, he had lost 30 pounds, and his blood pressure had decreased. In Henry’s case, his addiction to the food he used to eat was too difficult to overcome.
    By the very last day, day 30, incredible results were seen that significantly challenge the current belief that diabetes has no cure.
    • Kirt no longer needed medications. His blood sugar had dropped 214 points to as low as 73 (normal) without medication. It was later found out he was type 1 diabetic since the beginning.Status: Within normal range.
    • Bill stopped taking 19 medications and lost 32 pounds. His blood sugar dropped 214 points to 74 (normal) without medication or insulin. Status: Within normal range.
    • Michelle stopped taking all of her medications and lost 23 pounds. Her blood sugar dropped from 291 to 109 without the use of medication. Status: Within normal range.
    • Pam lost 26 pounds while her blood sugar dropped 167 points down to 112 without medication.Status: Within normal range.
    • Austin, who is type 1 diabetic, lost 20 pounds and reduced his insulin from 70 units down to 5.Status: Drastic improvement in diabetic condition.
    As you can see, all participants had drastic turnarounds in their health and all had their diabetes either completely reversed or brought well under control. A type 1 diabetic (Kirt) had his diabetes completely cured – something that is considered impossible. All type 2 diabetics no longer needed insulin.

    What Does This Tell Us?

    Like many things in modern medicine, we don’t have all of the answers and in a lot of cases we have a difficult time admitting that what is currently mainstream isn’t always the best course of action.
    People everywhere are taking alternate routes to achieve results equal to and sometimes better than what is made available to them through mainstream voices like doctors and government appointed professionals. I feel it’s important that people know their options and have a fair chance of hearing them out. I know many people with diabetes who aren’t aware of the power of food in transforming their condition yet are taking insulin and following mainstream ideas as if they were the only truth.
    It isn’t to say that the mainstream is bad, it’s simply that we are missing out on other options in a big way. After all, the American Diabetes Association makes claims about there being no cures yet the above results would suggest there is more to that story.
    Have you ever tried raw food to cure your diabetes? We are curious to hear some real live results from others.
    Sources:1. http://www.diabetes.org/diabetes-basics/statistics/
    2. http://care.diabetesjournals.org/content/24/11/1936.full
    3. http://www.medicinenet.com/diabetes_treatment/article.htm
    4. http://www.treehugger.com/culture/dr-gabriel-cousens-on-curing-diabetes-with-raw-food-and-on-why-going-vegan-makes-sense.html
    5. http://www.webmd.com/diabetes/blood-glucose-control

Thursday, 13 October 2016

India’s Craze for Ayurveda Is Producing Billionaires

A yoga teacher clad in white robes and often seen meditating on the banks of the Ganges is the latest to join the billionaires club in India.
But Acharya Balkrishna is no ordinary yoga teacher. He controls Patanjali Ayurved Ltd., the consumer-products company founded by his guru, Baba Ramdev, and whose Ayurvedic soaps, shampoos and food supplements are increasingly becoming staples in middle-class Indian homes. Indians’ craze for the company’s Ayurvedic formulations has seen Mr. Acharya’s net worth skyrocket to $3.8 billion, according to Hurun’s India Rich List for 2016. That puts him at number 25 in Hurun’s list of richest Indians, ahead of industrialists like Ratan Tata, Adi Godrej and Anand Mahindra.
Such is the demand for Patanjali, which sells creams, cleaners and hair conditioners rooted in Ayurveda, India’s traditional system of medicine, that the world’s biggest consumer-products makers are tweaking their products to compete. India’s traditional system of medicine encourages therapies like yoga and believes everything from the common cold to diabetes can be fixed by certain herbs, foods and oils.
Colgate Palmolive last month launched a toothpaste flavored with basil, clove and lemon. L’Oréal SA in June launched a new range of shampoos infused with eucalyptus, green tea and henna, an Indian herb Patanjali also packs in its shampoo. Unilever PLC recently purchased an Ayurvedic hair-care company.
Mr. Balkrishna is a reclusive figure next to Mr. Ramdev, one of India’s best-known yoga teachers who founded Patanjali in 2006 and has since transformed it into a multi-million dollar consumer goods empire. Mr. Balkrishna controls the business because Mr. Ramdev has sworn off most trappings of wealth. Click here to read The Wall Street Journal’s interview with Mr. Ramdev and for a tour around Patanjali’s manufacturing facility.
Messrs. Ramdev and Balkrishna are regularly seen practicing yoga on the banks of the Ganges in Haridwar, the Hindu holy city where Patanjali is based and where they run an ashram.
Ayurveda has produced other billionaires, too. The Burman family which runs Dabur India, another consumer-goods maker that draws inspiration from traditional Indian medicine, is 13th on Hurun’s India rich list.
Mukesh Ambani, the chairman of Reliance Industries, is the richest Indian with a net worth of $24 billion. Dilip Shanghvi, who heads generics-drug maker Sun Pharmaceutical Industries, is second with $18 billion in his kitty.
Source:Wall street journal

Facebook Badge

PAGE COUNTER